Skip to content

Different Endoscopic Gastric Cancer Risk Assessments

Different Endoscopic Gastric Cancer Risk Assessments for the Detection of Early Gastric Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05458388
Enrollment
3500
Registered
2022-07-14
Start date
2022-07-12
Completion date
2025-07-04
Last updated
2022-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer Screening

Brief summary

The Kimura-Takamoto classification established in Japan can observe the extent of gastric atrophy in real-time under endoscopy, and diffuse atrophy also indicates an increased risk of gastric cancer. Recent studies have found that the evaluation of intestinal metaplasia score (EGGIM score) of various stomach parts by electronic staining can well identify OLGIM III\\ IV patients. Although the Kimura-Takamoto classification and EGGIM score can evaluate the risk of gastric cancer in patients, only in cross-sectional studies, it is not clear the diagnostic value of risk assessment in population screening. Early gastric cancer has the characteristics of hidden lesions and a high rate of clinical missed diagnosis. Concentrating high-risk groups through risk scores is expected to guide endoscopic doctors to conduct a targeted careful examination. However, it is not clear whether Kimura-Takamoto classification and EGGIM score can improve the detection rate of early gastric cancer in clinical practice.

Interventions

PROCEDUREKimura-Takemoto classification

All patients were given two risk scores, the order of which was randomly determined.

PROCEDUREEGGIM

All patients were given two risk scores, the order of which was randomly determined.

Sponsors

Yanqing Li
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 40-80 years undergoing gastroscopy * Patients intend to undergo ESD treatment

Exclusion criteria

* patients with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who cannot participate in gastroscopy * Patients with previous surgical procedures on the stomach * patients with contraindications to biopsy * Patients who refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frameDescription
Early gastric cancer detection rate36 monthsThe detection rate of early gastric cancer

Countries

China

Contacts

Primary ContactYan-qing Li
liyanqing@sdu.edu.cn+8653188369277

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026